RGTI Stock Jumps As Benchmark Boosts Quantum Confidence

Rigetti Computing Inc. stocks have been trading up by 9.26 percent amid strong investor optimism over its latest quantum computing advances.

Live Update At 12:32:20 EDT: On Thursday, July 30, 2026 Rigetti Computing Inc. stock [NASDAQ: RGTI] is trending up by 9.26%! Discover the key drivers behind this movement as well as our expert analysis in the detailed breakdown below.

Quick Financial Overview

RGTI is trading like a classic story stock: tiny revenue, big narrative, heavy volatility. Over the last few weeks, Rigetti Computing has swung between roughly $13 and just above $18, then pulled back into the mid‑teens. The recent close around $14.45 shows that RGTI gave back some of the initial spike but is still holding well above short‑term lows.

On the intraday tape, Rigetti Computing spent most of the day grinding higher from the low $13s to the mid‑$14s, with tight five‑minute candles and shallow dips. That price action tells traders dip‑buyers are active and shorts are cautious about pressing.

Financially, RGTI remains early stage. The latest report shows about $7.1M in revenue and a sky‑high price‑to‑sales ratio above 500, which screams speculation, not value. Margins are deeply negative, and returns on equity and assets are both firmly in the red. The bright spot: a strong balance sheet with a current ratio near 7, low debt, and more than $418M in cash and short‑term investments. For traders, that cash runway reduces bankruptcy risk and keeps the quantum growth story alive while the company burns cash to build hardware.

Why Traders Are Watching Rigetti Computing Now

RGTI has suddenly moved back onto radar screens after a cluster of bullish catalysts. Benchmark initiated coverage on Rigetti Computing with a Buy rating and a $25 price target, a big call versus a stock trading in the mid‑teens. For active traders, that kind of upside target often acts like lighter fluid on a stock that already has a tight float and a strong story.

Benchmark also reinstated coverage on the broader quantum computing group with Buy ratings and aggressive targets on Rigetti, IonQ, and D‑Wave. That tells the market this isn’t just a one‑off call; it’s a sector thesis. When analysts frame quantum as a legitimate, long‑term theme, thematic funds and momentum traders tend to reach for a basket. RGTI benefits directly from that flow.

The real headline, though, is the TangleLab deal. Rigetti Computing will plug its 9‑qubit Novera quantum system into an NSF‑funded supercomputing testbed alongside Hewlett Packard Enterprise and the Pittsburgh Supercomputing Center. Construction is slated to start 2026/09/01, with operations expected as soon as the following year or by 2027. The market loved it. RGTI jumped about 12–12.5%, tagging roughly $15.92 on the news. That kind of fast move tells you algos and human traders are treating Rigetti as a go‑to quantum momentum name.

Layer on the narrative that Rigetti Computing is a superconducting quantum pure play with a letter of intent for up to $100M in CHIPS Act funding over three years, and you get a potent mix: government backing, big‑name partners, and analyst support. For short‑term traders, RGTI is a clean story to trade around headlines, milestones, and technical levels.

Conclusion

RGTI sits at the crossroads of hype and hard science. The company is still generating modest revenue, running heavy losses, and sporting extreme valuation ratios. Yet Rigetti Computing also has real assets: advanced qubit hardware, a deep cash pile, and access to public funding streams, plus validation from the NSF, HPE, and a fresh Buy rating from Benchmark with that $25 target.

For traders, the message is simple. RGTI is not a slow, steady compounder; it’s a high‑beta quantum vehicle that reacts fast to news. The TangleLab partnership, sector‑wide Buy calls, and potential CHIPS Act cash give Rigetti Computing a pipeline of catalysts that can fuel both sharp rallies and brutal pullbacks. The recent intraday grind from the low $13s to the mid‑$14s shows buyers stepping in on dips, but the long‑term chart still looks like a rollercoaster.

This is the kind of setup Tim Sykes talks about when he says, “I’m not here to be right, I’m here to trade well — that means cut losses quickly and never fall in love with a story.” His broader trading philosophy aligns perfectly with this type of volatile name: As millionaire penny stock trader and teacher Tim Sykes, says, “Cut losses quickly, let profits ride, and don’t overtrade.”. Applied to RGTI, that means respecting the upside while staying disciplined. Study the chart, track the news flow, and treat Rigetti Computing as a trading vehicle, not a guaranteed quantum future. This analysis is for educational and research purposes only and is not investment advice.

This is stock news, not investment advice. Timothy Sykes News delivers real-time stock market news focused on key catalysts driving short-term price movements. Our content is tailored for active traders and investors seeking to capitalize on rapid price fluctuations, particularly in volatile sectors like penny stocks. Readers come to us for detailed coverage on earnings reports, mergers, FDA approvals, new contracts, and unusual trading volumes that can trigger significant short-term price action. Some users utilize our news to explain sudden stock movements, while others rely on it for diligent research into potential investment opportunities.

Dive deeper into the world of trading with Timothy Sykes, renowned for his expertise in penny stocks. Explore his top picks and discover the strategies that have propelled him to success with these articles:

• Penny Stocks Trading Guide
• Best Penny Stocks Under $1 to Buy Today
• Top 8 Penny Stocks to Watch on Robinhood

Once you’ve got some stocks on watch, elevate your trading game with StocksToTrade the ultimate platform for traders. With specialized tools for swing and day trading, StocksToTrade will guide you through the market’s twists and turns.
Dig into StocksToTrade’s watchlists here:

• AI Penny Stocks
• Robinhood Penny Stocks
• Top Biotech Stocks